WATSON 453 (Guanfacine Hydrochloride 2 mg)
Pill with imprint WATSON 453 is Orange, Round and has been identified as Guanfacine Hydrochloride 2 mg. It is supplied by Watson Pharmaceuticals.
Guanfacine is used in the treatment of adhd; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 453
Guanfacine Hydrochloride
- Imprint:
- WATSON 453
- Strength:
- 2 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0453
- Inactive Ingredients:
-
- lactose anhydrous
- D&C Yellow No. 10
- FD&C Red No. 40
- povidone
- stearic acid
- microcrystalline cellulose
- aluminum oxide
Note: Inactive ingredients may vary.
More about guanfacine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 237 Reviews
- Drug class: antiadrenergic agents, centrally acting
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
